Home › Funds › NWI MANAGEMENT LP › RVMD
NWI MANAGEMENT LP position in RVMD
REVOLUTION MEDICINES INC · Health Care
NWI MANAGEMENT LP reported holding 180,000 shares of RVMD (REVOLUTION MEDICINES INC) in its Q3 2026 13F filing — a position valued at US$36.9M, representing 1.64% of its reported portfolio and ranking #13 among its reported holdings. NWI MANAGEMENT LP has disclosed RVMD holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How NWI MANAGEMENT LP's RVMD position evolved
NWI MANAGEMENT LP first disclosed a stake in RVMD in Q2 2026 at 180,000 shares (US$33.7M). The position peaked in Q3 2026 at 180,000 shares, worth US$36.9M. Across 2 filings, NWI MANAGEMENT LP held the position steady without any share-count change. The most recent filing (Q3 2026) shows 180,000 shares valued at US$36.9M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 180.00K | $33.71M | New |
| Q3 2026 | 180.00K | $36.95M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About RVMD and 13F data
RVMD (REVOLUTION MEDICINES INC) is a Health Care company. 58 other funds we track also report a position in RVMD — the largest reported positions include Farallon Capital Management (US$2.54B), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$2.54B), BAKER BROS. ADVISORS LP (US$2.14B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding RVMD
- Farallon Capital Management 13.55M sh · $2.54B · Q2 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 13.55M sh · $2.54B · Q2 2026
- BAKER BROS. ADVISORS LP 11.44M sh · $2.14B · Q2 2026
- Darwin Global Management, Ltd. 10.63M sh · $2.05B · Q2 2026
- Nextech Invest Ltd. 7.60M sh · $1.42B · Q2 2026
- Paradigm Biocapital Advisors LP 6.36M sh · $1.19B · Q2 2026
- Janus Henderson Group 9.77M sh · $949.54M · Q1 2026
- BVF INC/IL 2.97M sh · $555.32M · Q2 2026
- Alphabet Inc. 2.67M sh · $548.85M · Q3 2026
- Casdin Capital 2.58M sh · $482.68M · Q2 2026
- Assenagon Asset Management S.A. 2.18M sh · $447.71M · Q3 2026
- Avoro Capital Advisors LLC 2.30M sh · $430.18M · Q2 2026
More on NWI MANAGEMENT LP
FAQ
How long has NWI MANAGEMENT LP held RVMD?
NWI MANAGEMENT LP has disclosed RVMD holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is NWI MANAGEMENT LP's current position in RVMD?
As of Q3 2026, NWI MANAGEMENT LP holds 180.00K shares of RVMD (REVOLUTION MEDICINES INC), valued at $36.95M, representing 1.64% of its reported portfolio and ranking #13.
Has NWI MANAGEMENT LP been buying or selling RVMD?
In the latest 13F filing (Q3 2026), NWI MANAGEMENT LP held unchanged its position in RVMD. The position peaked in Q3 2026 at 180.00K shares.
Which other funds hold RVMD?
Other major institutional holders of RVMD include Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., BAKER BROS. ADVISORS LP, among 58 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.